CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project investigates the role of the Tumour Suppressor of Lung Cancer 1 (TSLC1) in lung diseases, particularly its influence on cell behavior and repair processes. By studying TSLC1's signaling pathways, the research aims to uncover new therapeutic targets for lung cancer and other chronic lung conditions.
Chronic lung diseases including COPD and cancer account for more than 10% of deaths in European countries and lung cancer remains the most common and most lethal cancer type worldwide.
Lung cancer mortality rates have also remained constant for over 40 years, largely due to late stage diagnosis and frequent metastases.
Despite these trends the signalling pathways regulating lung cancers remain largely unexplored.
Although loss of Tumour Suppressor of Lung Cancer 1 (TSLC1) is implicated in lung c…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
